The hemostasis diagnostic devices and equipment global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Hemostasis Diagnostic Devices And Equipment Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The hemostasis diagnostic devices and equipment market size has grown rapidly in recent years. It will grow from $5.48 billion in 2023 to $6.18 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to clinical diagnostics, surgical procedures, anticoagulant therapy monitoring, hemophilia and bleeding disorders.
The hemostasis diagnostic devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $9.85 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to aging population, cardiovascular and chronic diseases, personalized medicine, rising surgical procedures. Major trends in the forecast period include point-of-care testing, automation and robotics, biomarker discovery, telemedicine and remote monitoring.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report
Scope Of Hemostasis Diagnostic Devices And Equipment Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Hemostasis Diagnostic Devices And Equipment Market Overview
Market Drivers –
The increased likelihood of older people being diagnosed with a disease is driving the number of surgeries for cardiovascular diseases (CVD) using hemostasis devices. Due to the higher incidence of diseases with advancing age, there is an increase in the number of surgeries for elderly patients nowadays. These hemostasis devices are very efficient in speeding up the natural process of clotting in the blood and can monitor anticoagulation and transfusion therapy guidance in any surgery. According to the American Heart Association report, Americans older than 80 have a high risk of developing cardiovascular disease (CVD) around 83% of men and 87.1% of females will be suffering from any form of CVD, therefore, to improve the comfort of the patient and the success rate of surgeries as a result hemostasis device has been implemented widely.
Market Trends –
The emergence of new and improved technology in the hemostasis diagnostic device and equipment market. To improve the quality and success rate of operations, new and improved technology such as collagen vascular hemostasis devices have been implemented. Collagen is the main structural protein found in skin and other connective tissues. It is widely used in purified form for cosmetic surgical treatments and has now emerged in the hemostasis diagnostic devices market. A patient can face immobility right after a femoral surgery leading to increased discomfort, as a result, collagen-based closure devices have been implemented. According to a study conducted by the American Journal of Neuroradiology which surveyed 698 Angio-Seal closures, using the Angio seal reduced the average time before mobilization by close to 15 minutes with no major complications. Angio seal is a type of collagen hemostasis device that reduces the average time of hemostasis and betters the mobilization of the patient.
The hemostasis diagnostic devices and equipment market covered in this report is segmented –
1) By Product: Analyzers, Coagulation Instrument, Other Hemostasis Instruments, Reagents and Kits
2) By Device Technology: Automated, Semi-Automated, Manual
3) By End User: Hospitals, Clinics, Independent Diagnostic, Laboratories, Other End Users
Get an inside scoop of the hemostasis diagnostic devices and equipment market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=2598&type=smp
Regional Insights –
North America was the largest region in the global hemostasis diagnostic devices and equipment market in 2023. Asia-Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Key Companies –
Major companies operating in the hemostasis diagnostic devices and equipment market include C. R. Bard Inc., Baxter International Inc., Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Chrono-Log Corporation, CSL Behring LLC, F. Hoffmann-La Roche Ltd., Grifols S.A., HemCon Medical Technologies Inc., Integra Life Sciences Corporation, Medtronic plc, Siemens AG, Thermo Fisher Scientific Inc., Trinity Biotech plc., Ethicon Inc., Boston Scientific Corporation, Olympus Corporation, Cook Group Inc., Halyard Health, Medline Industries Inc., ConMed Corporation, Moog Inc., Argon Medical Devices Inc., B. Braun Interventional Systems Inc., Bio-Rad Laboratories Inc., CareFusion Corporation, Danaher Corporation, DemeTECH Corporation, Diagnostica Stago SAS, Dolphin Sutures, EndoEvolution LLC, Haemonetics Corporation, Internacional Farmacéutica S.A. de C.V., Merit Medical Systems Inc., Quidelortho Corp, STAGO, Stryker Corporation
Table of Contents
1. Executive Summary
2. Hemostasis Diagnostic Devices And Equipment Market Report Structure
3. Hemostasis Diagnostic Devices And Equipment Market Trends And Strategies
4. Hemostasis Diagnostic Devices And Equipment Market – Macro Economic Scenario
5. Hemostasis Diagnostic Devices And Equipment Market Size And Growth
…..
27. Hemostasis Diagnostic Devices And Equipment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
